This appointment represents an important step in our strategy to take advantage of Bovie
's existing R&D pipeline and leverage the capabilities of our in-house design team and our manufacturing facilities," Bovie
CEO Robert L.
Although it's a hassle, try to use a plastic Bovie
cup to holster the device whenever it's not in use.
With this additional exposure, Bovie
personnel engaged surgeons from around the world as well as from many of the most prestigious teaching hospitals in the United States.
Medical is a maker of medical devices and supplies as well as the developer of J-Plasma, a patented new plasma-based surgical product for cutting and coagulation.
TTI Medical San Ramon, CA Medisafe America Tampa, FL Palmero Health Care, Infection Control Stratford, CT Smoke Evacuators BERCHTOLD Corporation Charleston, SC Bovie
Bulgaria operates a 16,000 square foot ISO13485 certified and FDA registered manufacturing facility located in the capital city of Sofia, which houses manufacturing, development and assembly operations.
Commenting on the third quarter results, Andrew Makrides, president of Bovie
Medical Corporation, said, "The company believed it was in the best interest of shareholders to terminate the agreement with ART, involving ART's DYLYN(TM) coating.
M2 PHARMA-August 17, 2016-US FDA Clears Bovie
Medical's 'PlazXact' Ablator
Medical devices company Bovie
Medical (NYSE MKT:BVX) revealed on Wednesday the availability of its J-Plasma product extension, branded the Precise 360, in the prostate surgery industry.
Medical Corporation (the "Company") (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products and its new J-Plasma[TM] system, today announced that the Company will present at the 2012 SeeThru Equity Fall Smallcap and Microcap Conference Tuesday, October 2, 2012 at 11:20am ET, at The Cornell Club 6 East 44th Street New York City, New York.
M2 EQUITYBITES-October 21, 2015-Bovie
Medical buys its Bulgarian R&D and manufacturing contractor, Bovie
What sets this product apart from similar ones on the market today: According to Bovie
, the device reduces costs per case, streamlines inventory, allows for fewer staffing requirements, improves patient outcomes, and reduces procedural time with minimal capital investment.